ASX - Conference and earnings call announcements

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that its management will present at the following upcoming investor conferences: Cowen 41st Annual Healthcare ConferencePresenting on Thursday, March 4, 2021 at 11:10 a.m. Pacific Time / 2:10 p.m. Eastern Time (Australian time: Friday, March 5, 2021 at 6:10 a.m.) Oppenheimer 31st Annual Healthcare ConferencePresenting on Tuesday, March 16, 2021 at 12:50 p.m. Pacific Time / 3:50 p.

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 11, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today reported financial results for its second quarter of fiscal year 2021, ended December 31, 2020. Second Quarter Highlights Reported U.S based RECELL® revenue of $5.0 million in the second quarter of 2021 ended December 31, 2020, a 62% increase over the same quarter in the prior yearReported total global revenue of $5.1 million in the second quarter of 2021 ended December 31, 202

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that its management will present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 17, 2021 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time (February 18, 2021 at 8:30 am Melbourne time). Authorized for release by the Chief Executive Officer of AVITA Medical, Inc. ABOUT AVITA MEDICAL, INC.AVITA Medical is a regenerativ

VALENCIA, Calif. and MELBOURNE, Australia, Jan. 28, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today it plans to release its fiscal second quarter 2021 financial results after the market closes on Thursday, February 11, 2021. In conjunction with such release, the Company plans to host a conference call and webcast on February 11th at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. Interested parties may access the live call v